Solar Industries India Limited (SIIL) Share Price Analysis April 2026

Solar Industries India Limited (SIIL), incorporated in 1995 and headquartered in Nagpur, Maharashtra, is India’s largest manufacturer of industrial explosives and the country’s most strategically positioned private-sector defence explosives company. Once known as Solar Explosives Limited, it rebranded in 2009, reflecting its expanding scope far beyond conventional mining explosives.

The company serves two primary verticals. Its core industrial explosives franchise — spanning bulk emulsion explosives, packaged explosives, and electronic/non-electric detonating systems — supplies India’s mining, infrastructure, and construction sectors, with Coal India (CIL) and Singareni Collieries (SCCL) as anchor customers. Defence, the high-growth pillar, encompasses high-energy materials (HMX, RDX, TNT), ammunition, rockets and missiles (Pinaka MBRL), chaffs & flares, mines, aerial bombs, warheads, unmanned aerial systems (UAS/drones), and loitering munitions.

As of FY25, industrial explosives accounted for roughly 72% of revenues (down from 91% in FY22), while the defence segment has grown from 5.7% of FY23 revenues toward an estimated 28–34% by FY28. The company operates through 36 subsidiaries and 3 associates across 90+ countries, making it India’s largest explosives exporter. Overseas manufacturing is established in South Africa, Australia, Indonesia, and is being extended into Kazakhstan and Saudi Arabia.

The promoter family (Nuwal family) holds a 73.2% stake, underscoring long-term alignment. Chairman Satyanarayan Nuwal has steered the company from a single-product explosives manufacturer to a defence technology contender over three decades of disciplined capital allocation, a cultural moat that underpins SIIL’s long-duration investment thesis.

The financial trajectory of Solar Industries over the past five years reflects a company that successfully navigated a commodity supercycle, managed raw material cost volatility (ammonium nitrate surged ~80% in FY22), expanded margins as the product mix shifted toward defence, and delivered compounding profit growth at 36.2% CAGR over five years.

The FY24 revenue dip (-12.3%) was a product of ammonium nitrate price normalization and one-time inventory destocking — not a structural demand weakness. FY25’s 24% revenue rebound alongside a 44% EBITDA surge confirmed the margin inflection driven by high-margin defence revenue scaling. Q3 FY26’s 28.8% EBITDA margin (up from 27.2% in Q3 FY25) indicates the mix-shift trend continues uninterrupted.

Balance sheet quality is exceptional. Debt-to-equity has declined from a peak of 0.67x in FY12 to just 0.17x in FY25. Net debt turned negative (net cash) as recently as March 2025 before capex investment pushed it modestly positive in H1 FY26. The low dividend payout (7–9%) is deliberate — profits are being recycled into capacity-building for the defence segment, which is the highest-return use of capital at this stage of the company’s evolution.

A 10-year free cash flow discounted at a 12% WACC with a 5% terminal growth rate anchors our intrinsic value estimate. We model revenue growing at ~26% CAGR over FY25–FY28 (consensus), moderating to ~18% in FY29–FY32 as the defence segment matures, with EBITDA margins expanding to ~27%. FCF is constrained by significant capex (₹51.5 Bn guided for FY26–FY28) as SIIL builds out its defence manufacturing base.

The DCF is inherently conservative for SIIL — defence order execution, ammunition ramp-up (155mm, Pinaka), and loitering munitions commercialization all carry execution optionality that is not captured in our base DCF. Successful execution could materially expand the terminal value. The current CMP of ₹15,272 sits broadly within our DCF fair value band, suggesting the market is pricing in the base case with limited room for upside from DCF alone at current levels.

SIIL’s valuation premium relative to its industrial-chemicals peer group has structurally re-rated over the past three years as defence revenue has scaled. The stock’s one-year-forward P/E averaged 47.7x over the past five years — but has expanded sharply to the 60–90x range as defence order books and margin expansion have compressed the risk premium on earnings. Brokerages including Goldman Sachs, ICICI Direct, and Phillips Capital value SIIL on FY27–FY28 earnings with target P/Es of 60–72x, implying targets in the ₹15,450–₹18,900 range.

At ~90x TTM P/E, SIIL commands a meaningful premium over HAL and BEL, which is justified by its superior ROE (33% vs 26–28%), higher revenue CAGR, and the optionality of defence export orders into international markets — a capability that BEL and HAL do not yet possess at comparable scale. Against MTAR (146x) on weaker return ratios, SIIL’s premium appears more rational. The stock’s historical P/E band (5-year average ~48x) suggests at 90x it is trading at ~1.9x its historical average, which is elevated but defensible given the structural shift in the business mix.

An asset-based approach is most relevant as a floor-valuation check for SIIL, given the company’s capital-intensive manufacturing infrastructure across explosives and defence. The stock trades at approximately 27x book value (P/B ~27x), reflecting a substantial franchise premium — the market prices in intangible value from government certifications, manufacturing know-how in energetic materials, proprietary HMX/RDX formulations, and monopolistic positioning in several defence product categories.

The NAV approach yields a conservative fair value well below the market price, confirming that SIIL is a franchise-value stock rather than an asset-value stock. The premium P/B is entirely explained by the combination of exceptional return ratios (ROE ~33%) and the long-duration earnings visibility from the ₹21,000 Cr order book. For context, a company generating 33% ROE sustainably deserves to trade at 4–5x its sector peers’ P/B at minimum, which is consistent with the observed premium.

The Earnings Power Value methodology strips out growth assumptions and values SIIL as if its current normalized earnings persist indefinitely, capitalized at the cost of equity. Using a normalized FY25 EBIT of ~₹1,800 Cr, a 14% cost of equity (given the stock’s elevated beta in a high-valuation environment), and adjusting for net cash, the EPV arrives at a significant discount to the market price.

The gap between EPV (~₹9,000) and the current market price (~₹15,272) represents the “franchise value” the market assigns to SIIL’s expected defence growth trajectory and global expansion. This gap is wide — but historically justified by SIIL’s consistent ability to convert order book into earnings, which is the key execution variable to monitor. Any stumble in defence order execution or margin delivery could compress this gap rapidly.

SIIL’s transformation into a multi-segment entity — industrial explosives, defence, and international operations — warrants a SOTP approach that assigns differentiated multiples to each segment’s distinct risk-return profile. We apply segment-appropriate EV/EBITDA multiples derived from comparable pure-play peer sets.

Our SOTP yields a fair value of approximately ₹11,268 per share, which is notably below the current market price — reflecting the significant premium the market assigns to SIIL’s defence growth narrative. The SOTP serves as a conservative anchor; actual realization is contingent on the defence segment’s revenue scale reaching the assumed FY26E levels. Defence multiples (60x EV/EBITDA) are justified by comparison to pure-play defence manufacturers globally and domestically.

Our buy range synthesizes DCF, SOTP, relative valuation, and EPV into three action zones. Given SIIL’s growth profile, we weight the P/E-based relative valuation and DCF at 50:30, with SOTP and EPV providing the floor discipline.

The CMP of ₹15,272 falls in the upper half of the Accumulate zone — appropriate for systematic (SIP-style) accumulation rather than lump-sum deployment. Given the stock’s 52-week range of ₹11,646–₹17,820 and the geopolitical tailwind from India’s defence spending cycle, corrections to the ₹12,500–₹13,500 zone offer higher-conviction entry points. Investors with a 3-year horizon can accumulate at current levels given the FY28 earnings clarity.

SIIL is not a stock to exit lightly given the structural defence tailwind, but extreme valuation and execution risk at elevated prices warrant a disciplined exit framework. The sell range is calibrated to forward earnings, not historical P/E, given the multi-year earnings visibility.

Solar Industries is approaching a structural inflection that could reshape its earnings trajectory over the next five years. Three forces are compounding simultaneously: the Atmanirbhar Bharat push in defence indigenization, rising global geopolitical tensions driving ammunition demand, and SIIL’s unique positioning as the only private Indian company with end-to-end high-energy material capability.

Industrial Explosives (India): Coal production reached 1,047.69 MT in FY25, iron ore hit a record 289 MMT, and India’s construction market is projected to reach ₹88.3 lakh crore by 2030. These structural demand drivers for bulk and packaged explosives create a resilient, growing base business. SIIL’s dominant market share and long-term supply agreements with Coal India (₹2,229 Cr from CIL announced October 2025) ensure revenue floor protection.

Defence Ramp: The defence segment — growing at 72% YoY in FY25 — is entering a multi-year execution phase. Commercial production of 155mm calibre ammunition (expected Q4 FY26), Pinaka MBRL supply ramp (Q4 onwards), loitering munitions, and guided rocket systems represent the next revenue tranches. Export orders of ₹1,989 Cr (₹589 Cr + ₹1,400 Cr) to undisclosed international entities over 4 years add a geopolitical diversification premium. Management has guided ₹3,000 Cr of defence revenue in FY26.

International Expansion: Exports grew 69.2% YoY in FY25. SIIL operates in 90+ countries and is expanding manufacturing into Kazakhstan and Saudi Arabia. Overseas subsidiaries in South Africa, Australia, and Indonesia are scaling profitability. An MoU signed at Davos (January 2025) for large-scale international collaboration is expected to catalyze a ~₹12,700 Cr future opportunity pipeline.